Wakamoto Pharmaceutical Co.,Ltd. (4512.T)

JPY 231.0

(0.87%)

Market Cap (In JPY)

8.01 Billion

Revenue (In JPY)

7.73 Billion

Net Income (In JPY)

108.95 Million

Avg. Volume

376.51 Thousand

Currency
JPY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
190.0-324.0
PE
-
EPS
-
Beta Value
0.563
ISIN
JP3991200001
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Arata Igarashi
Employee Count
-
Website
https://www.wakamoto-pharm.co.jp
Ipo Date
2001-01-01
Details
Wakamoto Pharmaceutical Co., Ltd. manufactures and sells ethical and non-prescription drugs in Japan. The company offers Strong Wakamoto, a gastrointestinal drug for digestion, intestinal regulation, and nutritional supplementation. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co., Ltd. in July 1943. Wakamoto Pharmaceutical Co., Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.